Search PubMed⌕ Search

Biomedical subjects

J A Dormandy

Publications and source records attributed to J A Dormandy.

At least 127 records · Page 7Linked to original sources
PubMed1975

Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.

Ankle systolic pressure measurements in 67 patients with intermittent claudication treated with Clofibrate for an average period of 11 months and 32 untreated patients suggest that 1) patients with a raised initial plasma fibrinogen concentration have more severe disease than those with low initial plasma fibrinogen concentration and 2) the response to treatment with Clofibrate is significantly better in those with a raised plasma fibrinogen concentration. On the basis of the patients own estimation of their claudication distance there was marked symptomatic inprovement in the treated patients. There was also a significant decrease in mean plasma fibrinogen levels in the treated patients and it is suggested that the hypofibrinogenemic effect of Clofibrate may be responsible for the benefit of this drug in patients with vascular disease.

Ankle↗
PubMed1974

Effect of clofibrate on blood viscosity in intermittent claudication.

Sixty-two patients with intermittent claudication associated with peripheral arterial diseases were treated with clofibrate, 2 g daily, for a minimum of six months. Progress was compared with that in a similar pretreatment period and also with that of a matched untreated control group of 27 patients. The most striking effect of clofibrate was a steep and sustained fall in whole-blood viscosity measured over a wide range of shear rates. This was associated with a significant fall in abnormally raised initial plasma-fibrinogen levels. An increased proportion of patients on treatment showed evidence of clinical improvement. Clofibrate had no effect on the susceptibility of red blood cells to autoxidation but it led to a significant shift in the red cell fatty acid pattern.

Blood Viscosity↗
PubMed1973

Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication.

Increased blood viscosity has been shown to be an important factor in reducing blood flow in a review and analysis of the history, clinical findings, and haemodynamic, rheological, radiological, and biochemical measurements in 126 patients with intermittent claudication. In some patients increased viscosity seemed to be the determining cause of claudication. A raised plasma fibrinogen was the most common single biochemical abnormality. The results of conventional serum lipid and lipoprotein estimations were abnormal in the series as a whole but did not correlate with clinical findings or flow measurements at individual patient level. There was, however, a significant correlation between some clinical findings and the susceptibility of the red cells to autoxidation.

Adult↗
PubMed1973

Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.

To assess the prognostic significance of clinical and laboratory findings in intermittent claudication a group of 62 untreated patients was followed up in detail for periods of from one to three years. There was a significant correlation between progressive deterioration of the peripheral circulatory disturbance and the initial blood viscosity, the plasma fibrinogen level, and the susceptibility of red cell lipids to autoxidation.

Adult↗
PubMed1971

Influence of blood viscosity on blood flow and the effect of low molecular weight dextran.

Changes in whole blood viscosity are related to changes in the leg blood flow during infusions of low-molecular-weight dextran and Hartmann's solution. A close inverse correlation exists between changes in viscosity and blood flow, the change in blood flow being about three times greater than the change in blood viscosity. The dextran and Hartmann's solution had a similar effect on blood viscosity and blood flow if corrections are made for the difference in haemodilution.

Blood Flow Velocity↗